{"transactions":[{"id":1869843,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-02T17:21:14.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":18475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 100% on the earlier of (i) June 1, 2024 or (ii) the day immediately preceding the day of the following year's annual meeting."}],"balance_after":18475,"derivative":{"exercise_price":38.96,"expiration_date":"2033-06-01","underlying":"Common Shares","underlying_shares":18475},"source":{"system":"sec-edgar","filing":"0000950170-23-026169","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023026169/ownership.xml","form_type":"4"}},{"id":1871949,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-01T19:25:51.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The shares subject to the options are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":17.76,"expiration_date":"2025-03-16","underlying":"Common Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871948,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-01T19:25:51.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":false,"shares":9318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The shares subject to the options are fully vested and exercisable."}],"balance_after":30682,"derivative":{"exercise_price":7.69,"expiration_date":"2025-12-17","underlying":"Common Shares","underlying_shares":9318},"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871947,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-01T19:25:51.000Z","date":"2023-05-31","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The shares subject to the options are fully vested and exercisable."}],"balance_after":45000,"derivative":{"exercise_price":17.76,"expiration_date":"2025-03-16","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871946,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-01T19:25:51.000Z","date":"2023-05-31","kind":"exercise","planned":false,"acquired":false,"shares":29835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The shares subject to the options are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":9.85,"expiration_date":"2024-01-13","underlying":"Common Shares","underlying_shares":29835},"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871945,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-06-01T19:25:51.000Z","date":"2023-06-01","kind":"sale","planned":false,"acquired":false,"shares":24255,"price":38.78,"value":940608.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.78 to $38.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871944,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-06-01T19:25:51.000Z","date":"2023-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":20745,"price":38.53,"value":799304.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the closing price of the Company's common shares on May 31, 2023 for purposes of net settlement calculations."}],"balance_after":30255,"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871943,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-06-01T19:25:51.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":true,"shares":45000,"price":17.76,"value":799200.0,"ownership":{"direct":true},"balance_after":51000,"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871942,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-06-01T19:25:51.000Z","date":"2023-06-01","kind":"sale","planned":false,"acquired":false,"shares":7458,"price":38.97,"value":290638.26,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871941,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-06-01T19:25:51.000Z","date":"2023-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1860,"price":38.53,"value":71665.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the closing price of the Company's common shares on May 31, 2023 for purposes of net settlement calculations."}],"balance_after":13458,"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871940,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-06-01T19:25:51.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":true,"shares":9318,"price":7.69,"value":71655.42,"ownership":{"direct":true},"balance_after":15318,"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871939,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-06-01T19:25:51.000Z","date":"2023-05-31","kind":"sale","planned":false,"acquired":false,"shares":26856,"price":38.69,"value":1039058.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.50 to $38.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871938,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-06-01T19:25:51.000Z","date":"2023-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":23144,"price":38.37,"value":888035.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the closing price of the Company's common shares on May 30, 2023 for purposes of net settlement calculations."}],"balance_after":32856,"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871937,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-06-01T19:25:51.000Z","date":"2023-05-31","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":17.76,"value":888000.0,"ownership":{"direct":true},"balance_after":56000,"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871936,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-06-01T19:25:51.000Z","date":"2023-05-31","kind":"sale","planned":false,"acquired":false,"shares":23670,"price":38.81,"value":918632.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.66 to $39.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871935,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-06-01T19:25:51.000Z","date":"2023-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":6165,"price":38.37,"value":236551.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the closing price of the Company's common shares on May 30, 2023 for purposes of net settlement calculations."}],"balance_after":29670,"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871934,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-06-01T19:25:51.000Z","date":"2023-05-31","kind":"exercise","planned":false,"acquired":true,"shares":29835,"price":9.85,"value":293874.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":35835,"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871933,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-06-01T19:25:51.000Z","date":"2023-05-31","kind":"sale","planned":false,"acquired":false,"shares":12000,"price":38.53,"value":462360.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.20 to $38.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871932,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-06-01T19:25:51.000Z","date":"2023-05-30","kind":"sale","planned":false,"acquired":false,"shares":19000,"price":39.9,"value":758100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":18000,"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1871931,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-06-01T19:25:51.000Z","date":"2023-05-30","kind":"sale","planned":false,"acquired":false,"shares":18006,"price":38.63,"value":695571.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.50 to $39.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":37000,"source":{"system":"sec-edgar","filing":"0000950170-23-025802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000095017023025802/ownership.xml","form_type":"4"}},{"id":1960990,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-09T18:21:59.000Z","date":"2023-03-07","kind":"exercise","acquired":false,"shares":30864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the options are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.59,"expiration_date":"2023-03-09","underlying":"Common Shares","underlying_shares":30864},"source":{"system":"sec-edgar","filing":"0001209191-23-017636","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919123017636/doc4.xml","form_type":"4"}},{"id":1960989,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-09T18:21:59.000Z","date":"2023-03-07","kind":"exercise","acquired":false,"shares":41152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the options are fully vested and exercisable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period."}],"balance_after":0,"derivative":{"exercise_price":2.68,"expiration_date":"2023-03-10","underlying":"Common Shares","underlying_shares":41152},"source":{"system":"sec-edgar","filing":"0001209191-23-017636","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919123017636/doc4.xml","form_type":"4"}},{"id":1960988,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-03-09T18:21:59.000Z","date":"2023-03-07","kind":"sale","acquired":false,"shares":8242,"price":36.94,"value":304459.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $36.89 to $37.03, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":55006,"source":{"system":"sec-edgar","filing":"0001209191-23-017636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919123017636/doc4.xml","form_type":"4"}},{"id":1960987,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-03-09T18:21:59.000Z","date":"2023-03-07","kind":"tax_withholding","acquired":false,"shares":1618,"price":37.13,"value":60076.34,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of the Company's common shares on March 6, 2023 for purposes of net settlement calculations."}],"balance_after":63248,"source":{"system":"sec-edgar","filing":"0001209191-23-017636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919123017636/doc4.xml","form_type":"4"}},{"id":1960986,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-03-09T18:21:59.000Z","date":"2023-03-07","kind":"exercise","acquired":true,"shares":30864,"price":2.59,"value":79937.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":64866,"source":{"system":"sec-edgar","filing":"0001209191-23-017636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919123017636/doc4.xml","form_type":"4"}},{"id":1960985,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-03-09T18:21:59.000Z","date":"2023-03-07","kind":"sale","acquired":false,"shares":10990,"price":37.01,"value":406739.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $36.93 to $37.13, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":34002,"source":{"system":"sec-edgar","filing":"0001209191-23-017636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919123017636/doc4.xml","form_type":"4"}},{"id":1960984,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-03-09T18:21:59.000Z","date":"2023-03-07","kind":"tax_withholding","acquired":false,"shares":2160,"price":37.13,"value":80200.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of the Company's common shares on March 6, 2023 for purposes of net settlement calculations."}],"balance_after":44992,"source":{"system":"sec-edgar","filing":"0001209191-23-017636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919123017636/doc4.xml","form_type":"4"}},{"id":1960983,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-03-09T18:21:59.000Z","date":"2023-03-07","kind":"exercise","acquired":true,"shares":41152,"price":2.68,"value":110287.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":47152,"source":{"system":"sec-edgar","filing":"0001209191-23-017636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919123017636/doc4.xml","form_type":"4"}},{"id":2184176,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-08-16T17:31:10.000Z","date":"2022-08-16","kind":"sale","acquired":false,"shares":20000,"price":38.87,"value":777400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.70 to $39.20, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-22-046015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122046015/doc4.xml","form_type":"4"}},{"id":2184175,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-08-16T17:31:10.000Z","date":"2022-08-16","kind":"sale","acquired":false,"shares":32058,"price":38.29,"value":1227500.82,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $37.6431 to $38.6033, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":26000,"source":{"system":"sec-edgar","filing":"0001209191-22-046015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122046015/doc4.xml","form_type":"4"}},{"id":2184174,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-08-16T17:31:10.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":33942,"price":37.76,"value":1281649.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $37.5022 to $38.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":58058,"source":{"system":"sec-edgar","filing":"0001209191-22-046015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122046015/doc4.xml","form_type":"4"}},{"id":2184173,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-08-16T17:31:10.000Z","date":"2022-08-12","kind":"sale","acquired":false,"shares":1000,"price":39.15,"value":39150.0,"ownership":{"direct":true},"balance_after":92000,"source":{"system":"sec-edgar","filing":"0001209191-22-046015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122046015/doc4.xml","form_type":"4"}},{"id":2184172,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-08-16T17:31:10.000Z","date":"2022-08-12","kind":"sale","acquired":false,"shares":47000,"price":38.6,"value":1814200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.1397 to $39.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein"}],"balance_after":93000,"source":{"system":"sec-edgar","filing":"0001209191-22-046015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122046015/doc4.xml","form_type":"4"}},{"id":2184171,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-08-16T17:31:10.000Z","date":"2022-08-12","kind":"sale","acquired":false,"shares":43135,"price":37.91,"value":1635247.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $37.1353 to $38.1084, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":140000,"source":{"system":"sec-edgar","filing":"0001209191-22-046015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122046015/doc4.xml","form_type":"4"}},{"id":2219368,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T17:48:56.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the common shares subject to the option will vest on the earlier of (i) the first anniversary of grant date and (ii) the day immediately preceding the day of the Issuer's next annual general meeting of shareholders."}],"balance_after":18000,"derivative":{"exercise_price":30.11,"expiration_date":"2032-06-27","underlying":"Common Shares","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-22-039837","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122039837/doc4.xml","form_type":"4"}},{"id":2335458,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-14T16:20:17.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2023 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":25000,"derivative":{"exercise_price":30.01,"expiration_date":"2032-03-09","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-018457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122018457/doc4.xml","form_type":"4"}},{"id":2344424,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T21:41:24.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":2500,"price":30.8,"value":77000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.800 to $30.880, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":193135,"source":{"system":"sec-edgar","filing":"0001209191-22-017418","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017418/doc4a.xml","form_type":"4/A","original_submission_date":"2022-03-08"}},{"id":2344445,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-07","kind":"exercise","acquired":false,"shares":20576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"25% of the shares subject to the Option vested on the one year anniversary of January 1, 2012 (the \"2012 Vesting Commencement Date\") and thereafter 1/48th of the\nshares subject to the Option vest on each monthly anniversary of the 2012 Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F13","text":"Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period."}],"balance_after":0,"derivative":{"exercise_price":3.67,"expiration_date":"2022-03-10","underlying":"Common Shares","underlying_shares":20576},"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344444,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-04","kind":"exercise","acquired":false,"shares":10288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"25% of the shares subject to the Option vested on the one year anniversary of January 1, 2012 (the \"2012 Vesting Commencement Date\") and thereafter 1/48th of the\nshares subject to the Option vest on each monthly anniversary of the 2012 Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F13","text":"Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period."}],"balance_after":0,"derivative":{"exercise_price":3.67,"expiration_date":"2022-03-10","underlying":"Common Shares","underlying_shares":10288},"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344443,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":2500,"price":30.5,"value":76250.0,"ownership":{"direct":true},"balance_after":183135,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344442,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":2500,"price":30.55,"value":76375.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.55 to $30.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein"}],"balance_after":185635,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344441,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":2500,"price":30.2,"value":75500.0,"ownership":{"direct":true},"balance_after":188135,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344440,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":2500,"price":30.1,"value":75250.0,"ownership":{"direct":true},"balance_after":190635,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344439,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":2500,"price":3.8,"value":9500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.800 to $30.880, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":193135,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344438,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":2051,"price":30.6,"value":62760.6,"ownership":{"direct":true},"balance_after":195635,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344437,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":2500,"price":30.55,"value":76375.0,"ownership":{"direct":true},"balance_after":197686,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344436,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":7500,"price":30.5,"value":228750.0,"ownership":{"direct":true},"balance_after":200186,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344435,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":2500,"price":30.52,"value":76300.0,"ownership":{"direct":true},"balance_after":207686,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344434,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":4516,"price":30.44,"value":137467.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.40 to $30.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":210186,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344433,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":4516,"price":30.45,"value":137512.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.4100 to $30.4750, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":214702,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344432,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":4517,"price":30.49,"value":137723.33,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.480 to $30.645, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":219218,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344431,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":5037,"price":30.6,"value":154132.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.4865 to $30.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":223735,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344430,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-07","kind":"tax_withholding","acquired":false,"shares":1990,"price":30.23,"value":60157.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the closing price of the Company's common shares on March 4, 2022, which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":228772,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344429,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-07","kind":"exercise","acquired":true,"shares":20576,"price":3.67,"value":75513.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."}],"balance_after":230762,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344428,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":4793,"price":30.56,"value":146474.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.53 to $30.61, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":210186,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344427,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":4532,"price":30.66,"value":138951.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.49 to $30.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":214979,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344426,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-04","kind":"tax_withholding","acquired":false,"shares":963,"price":31.42,"value":30257.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of the Company's common shares on March 3, 2022, which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":219511,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2344425,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T19:58:33.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":10288,"price":3.67,"value":37756.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."}],"balance_after":220474,"source":{"system":"sec-edgar","filing":"0001209191-22-017341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919122017341/doc4.xml","form_type":"4"}},{"id":2510616,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-11-16T20:40:42.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":17557,"price":31.33,"value":550060.81,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $31.10 to $31.85, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein"}],"balance_after":210186,"source":{"system":"sec-edgar","filing":"0001209191-21-064931","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919121064931/doc4.xml","form_type":"4"}},{"id":2695136,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-26T16:11:16.000Z","date":"2021-05-24","kind":"exercise","acquired":false,"shares":22633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Option vested on the one year anniversary of January 1, 2011 (the \"2011 Vesting Commencement Date\") and thereafter 1/48th of the shares subject to the Option vest on each monthly anniversary of the 2011 Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period and a lock-up agreement period."}],"balance_after":0,"derivative":{"exercise_price":3.76,"expiration_date":"2021-05-28","underlying":"Common Shares","underlying_shares":22633},"source":{"system":"sec-edgar","filing":"0001209191-21-035911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919121035911/doc4.xml","form_type":"4"}},{"id":2695135,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2021-05-26T16:11:16.000Z","date":"2021-05-24","kind":"tax_withholding","acquired":false,"shares":5076,"price":19.17,"value":97306.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of the Company's common shares on May 21, 2021, which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":227743,"source":{"system":"sec-edgar","filing":"0001209191-21-035911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919121035911/doc4.xml","form_type":"4"}},{"id":2695134,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2021-05-26T16:11:16.000Z","date":"2021-05-24","kind":"exercise","acquired":true,"shares":22633,"price":3.76,"value":85100.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":232819,"source":{"system":"sec-edgar","filing":"0001209191-21-035911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919121035911/doc4.xml","form_type":"4"}},{"id":2789187,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-15T16:41:26.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2022 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":225000,"derivative":{"exercise_price":20.55,"expiration_date":"2031-03-11","underlying":"Common Shares","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-21-020478","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919121020478/doc4.xml","form_type":"4"}},{"id":3048741,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2020-08-24T16:41:10.000Z","date":"2020-08-20","kind":"other","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Since the date of the reporting person's last ownership report, he transferred 45,000 common shares to his spouse pursuant to the terms of a settlement agreement dated August 20, 2020 and filed with the Supreme Court of British Columbia in Vancouver, British Columbia on August 21, 2020.  The settlement agreement was entered into in connection with the anticipated dissolution of the reporting person's marriage. The reporting person no longer reports as beneficially owned any securities owned by his spouse."}],"balance_after":210186,"source":{"system":"sec-edgar","filing":"0001209191-20-048095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919120048095/doc4.xml","form_type":"4"}},{"id":3127103,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2020-06-02T16:50:22.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":3000,"price":14.43,"value":43290.0,"ownership":{"direct":true},"balance_after":255186,"source":{"system":"sec-edgar","filing":"0001209191-20-033578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919120033578/doc4.xml","form_type":"4"}},{"id":3127102,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2020-06-02T16:50:22.000Z","date":"2020-05-29","kind":"sale","acquired":false,"shares":5000,"price":13.99,"value":69950.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $13.99 to $14.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein"}],"balance_after":258186,"source":{"system":"sec-edgar","filing":"0001209191-20-033578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919120033578/doc4.xml","form_type":"4"}},{"id":3132179,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-28T17:02:03.000Z","date":"2020-05-26","kind":"exercise","acquired":false,"shares":6172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option fully vested on December 31, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3.56,"expiration_date":"2020-06-02","underlying":"Common Shares","underlying_shares":6172},"source":{"system":"sec-edgar","filing":"0001209191-20-032628","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919120032628/doc4.xml","form_type":"4"}},{"id":3132178,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2020-05-28T17:02:03.000Z","date":"2020-05-26","kind":"tax_withholding","acquired":false,"shares":1108,"price":14.9,"value":16509.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of the Company's common shares on May 22, 2020, which was converted to a Canadian dollar amount for purposes of net settlement calculations"}],"balance_after":263186,"source":{"system":"sec-edgar","filing":"0001209191-20-032628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919120032628/doc4.xml","form_type":"4"}},{"id":3132177,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2020-05-28T17:02:03.000Z","date":"2020-05-26","kind":"exercise","acquired":true,"shares":6172,"price":3.56,"value":21972.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":264294,"source":{"system":"sec-edgar","filing":"0001209191-20-032628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919120032628/doc4.xml","form_type":"4"}},{"id":3211093,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-13T17:00:21.000Z","date":"2020-03-12","kind":"grant","acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2021 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":280000,"derivative":{"exercise_price":11.58,"expiration_date":"2030-03-11","underlying":"Common Shares","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001209191-20-018941","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919120018941/doc4.xml","form_type":"4"}},{"id":3407010,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2019-09-24T18:14:15.000Z","date":"2019-09-20","kind":"sale","acquired":false,"shares":10395,"price":9.51,"value":98856.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $9.50 to $9.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein"}],"balance_after":258122,"source":{"system":"sec-edgar","filing":"0001209191-19-050588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919119050588/doc4.xml","form_type":"4"}},{"id":3410899,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-18T19:06:51.000Z","date":"2019-09-17","kind":"exercise","acquired":false,"shares":12345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option fully vested on August 31, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3.38,"expiration_date":"2019-09-18","underlying":"Common Shares","underlying_shares":12345},"source":{"system":"sec-edgar","filing":"0001209191-19-050148","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919119050148/doc4.xml","form_type":"4"}},{"id":3410898,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-18T19:06:51.000Z","date":"2019-09-17","kind":"exercise","acquired":false,"shares":9259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option fully vested on December 31, 2012. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3.07,"expiration_date":"2019-09-18","underlying":"Common Shares","underlying_shares":9259},"source":{"system":"sec-edgar","filing":"0001209191-19-050148","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919119050148/doc4.xml","form_type":"4"}},{"id":3410897,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-18T19:06:51.000Z","date":"2019-09-17","kind":"exercise","acquired":false,"shares":36008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option fully vested on May 31, 2011. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3.7,"expiration_date":"2019-09-18","underlying":"Common Shares","underlying_shares":36008},"source":{"system":"sec-edgar","filing":"0001209191-19-050148","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919119050148/doc4.xml","form_type":"4"}},{"id":3410896,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-18T19:06:51.000Z","date":"2019-09-16","kind":"grant","acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vesting over 36 months, in equal amounts, on the last day of each month."}],"balance_after":280000,"derivative":{"exercise_price":9.44,"expiration_date":"2029-09-15","underlying":"Common Shares","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001209191-19-050148","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919119050148/doc4.xml","form_type":"4"}},{"id":3410895,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2019-09-18T19:06:51.000Z","date":"2019-09-17","kind":"tax_withholding","acquired":false,"shares":3692,"price":9.44,"value":34852.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of the Company's common shares on September 16, 2019, which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":268517,"source":{"system":"sec-edgar","filing":"0001209191-19-050148","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919119050148/doc4.xml","form_type":"4"}},{"id":3410894,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2019-09-18T19:06:51.000Z","date":"2019-09-17","kind":"exercise","acquired":true,"shares":12345,"price":3.38,"value":41726.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":272209,"source":{"system":"sec-edgar","filing":"0001209191-19-050148","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919119050148/doc4.xml","form_type":"4"}},{"id":3410893,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2019-09-18T19:06:51.000Z","date":"2019-09-17","kind":"tax_withholding","acquired":false,"shares":2769,"price":9.44,"value":26139.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of the Company's common shares on September 16, 2019, which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":259864,"source":{"system":"sec-edgar","filing":"0001209191-19-050148","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919119050148/doc4.xml","form_type":"4"}},{"id":3410892,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2019-09-18T19:06:51.000Z","date":"2019-09-17","kind":"exercise","acquired":true,"shares":9259,"price":3.07,"value":28425.13,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":262633,"source":{"system":"sec-edgar","filing":"0001209191-19-050148","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919119050148/doc4.xml","form_type":"4"}},{"id":3410891,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2019-09-18T19:06:51.000Z","date":"2019-09-17","kind":"tax_withholding","acquired":false,"shares":10769,"price":9.44,"value":101659.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of the Company's common shares on September 16, 2019, which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":253374,"source":{"system":"sec-edgar","filing":"0001209191-19-050148","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919119050148/doc4.xml","form_type":"4"}},{"id":3410890,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2019-09-18T19:06:51.000Z","date":"2019-09-17","kind":"exercise","acquired":true,"shares":36008,"price":3.7,"value":133229.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":264143,"source":{"system":"sec-edgar","filing":"0001209191-19-050148","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000120919119050148/doc4.xml","form_type":"4"}},{"id":3996370,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-14T16:52:52.000Z","date":"2018-03-12","kind":"exercise","acquired":false,"shares":10288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option fully vested on December 31, 2011.  The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3.77,"expiration_date":"2018-03-16","underlying":"Common Shares","underlying_shares":10288},"source":{"system":"sec-edgar","filing":"0001171843-18-001956","document":"f4_pimstone031418.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000117184318001956/f4_pimstone031418.xml","form_type":"4"}},{"id":3996369,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2018-03-14T16:52:52.000Z","date":"2018-03-12","kind":"exercise","acquired":true,"shares":10288,"price":3.77,"value":38785.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."}],"balance_after":228135,"source":{"system":"sec-edgar","filing":"0001171843-18-001956","document":"f4_pimstone031418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000117184318001956/f4_pimstone031418.xml","form_type":"4"}},{"id":3998412,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-13T17:40:42.000Z","date":"2018-03-12","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2019, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":140000,"derivative":{"exercise_price":4.75,"expiration_date":"2028-03-11","underlying":"Common Shares","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001171843-18-001913","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000117184318001913/formfour.xml","form_type":"4"}},{"id":4181231,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-24T18:46:16.000Z","date":"2017-10-23","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on October 23, 2018, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":11000,"derivative":{"exercise_price":3.1,"expiration_date":"2027-10-22","underlying":"Common Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001171843-17-006256","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000117184317006256/formfour.xml","form_type":"4"}},{"id":4235331,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Shares","published_at":"2017-08-14T18:06:39.000Z","date":"2017-08-10","kind":"purchase","acquired":true,"shares":6000,"price":2.9,"value":17400.0,"ownership":{"direct":true},"balance_after":217847,"source":{"system":"sec-edgar","filing":"0001171843-17-005069","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000117184317005069/formfour.xml","form_type":"4"}},{"id":4386362,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":112810,"kind":"person","name":"PIMSTONE SIMON N.","position":1,"cik":"0001620084","reported_name":"PIMSTONE SIMON N.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-14T16:26:37.000Z","date":"2017-03-13","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2018, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":140000,"derivative":{"exercise_price":8.4,"expiration_date":"2027-03-12","underlying":"Common Shares","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001171843-17-001507","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620084/000117184317001507/formfour.xml","form_type":"4"}}]}